Laura Gosselin1, Maxime Thibault2, Denis Lebel3, Jean-François Bussières4. 1. travaille à l'Unité de recherche en pratique pharmaceutique, Département de pharmacie, CHU Sainte-Justine, Montréal (Québec). Elle est aussi candidate au Pharm. D. à l'Université de Lille, Lille (France). 2. , B. Pharm., M. Sc., travaille à l'Unité de recherche en pratique pharmaceutique, Département de pharmacie, CHU Sainte-Justine, Montréal (Québec). 3. , M. Sc., FCSHP, travaille à l'Unité de recherche en pratique pharmaceutique, Département de pharmacie, CHU Sainte-Justine, Montréal (Québec). 4. , B. Pharm., M. Sc., MBA, FCSHP, FOPQ, travaille à l'Unité de recherche en pratique pharmaceutique, Département de pharmacie, CHU Sainte-Justine, et à la Faculté de pharmacie, Université de Montréal, Montréal (Québec).
Abstract
BACKGROUND: Artificial intelligence (AI) can be described as an advanced technology in which machines display a certain form of intelligence. OBJECTIVES: The primary objective was to perform a narrative review of studies evaluating the feasibility and impact of AI in pharmacy. The secondary objective was to create a mind map of AI in health care. DATA SOURCES: Four databases were consulted: PubMed, Medline, Embase, and CINAHL. STUDY SELECTION AND DATA EXTRACTION: Four search strategies were developed. Initial selection of articles was based on their titles and abstracts; the full texts were then evaluated by a research assistant, with review by a pharmacist. Articles were included if they described or evaluated the feasibility or impact of AI in pharmacy. DATA SYNTHESIS: A total of 362 articles were identified by the literature review, of which 18 met the inclusion criteria. The studies were mainly conducted in the United States (72%, 13/18). The article topics were, in decreasing order, prediction of response to treatments and adverse effects (33%, 6/18), patient prioritization (28%, 5/18), treatment adherence (22%, 4/18), validation of prescriptions and electronic prescription (17%, 3/18), and other themes (e.g., diagnosis, costs, insurance, and verification of syringe volume). CONCLUSIONS: This narrative review highlighted 18 studies evaluating the feasibility and impact of AI in pharmacy. The studies used various methodologies in different settings, both retail pharmacies and hospital pharmacies. It is still too soon to predict the implications of AI for pharmacy, but these studies emphasize the importance of attention in this area. 2021 Canadian Society of Hospital Pharmacists. All content in the Canadian Journal of Hospital Pharmacy is copyrighted by the Canadian Society of Hospital Pharmacy. In submitting their manuscripts, the authors transfer, assign, and otherwise convey all copyright ownership to CSHP.
BACKGROUND: Artificial intelligence (AI) can be described as an advanced technology in which machines display a certain form of intelligence. OBJECTIVES: The primary objective was to perform a narrative review of studies evaluating the feasibility and impact of AI in pharmacy. The secondary objective was to create a mind map of AI in health care. DATA SOURCES: Four databases were consulted: PubMed, Medline, Embase, and CINAHL. STUDY SELECTION AND DATA EXTRACTION: Four search strategies were developed. Initial selection of articles was based on their titles and abstracts; the full texts were then evaluated by a research assistant, with review by a pharmacist. Articles were included if they described or evaluated the feasibility or impact of AI in pharmacy. DATA SYNTHESIS: A total of 362 articles were identified by the literature review, of which 18 met the inclusion criteria. The studies were mainly conducted in the United States (72%, 13/18). The article topics were, in decreasing order, prediction of response to treatments and adverse effects (33%, 6/18), patient prioritization (28%, 5/18), treatment adherence (22%, 4/18), validation of prescriptions and electronic prescription (17%, 3/18), and other themes (e.g., diagnosis, costs, insurance, and verification of syringe volume). CONCLUSIONS: This narrative review highlighted 18 studies evaluating the feasibility and impact of AI in pharmacy. The studies used various methodologies in different settings, both retail pharmacies and hospital pharmacies. It is still too soon to predict the implications of AI for pharmacy, but these studies emphasize the importance of attention in this area. 2021 Canadian Society of Hospital Pharmacists. All content in the Canadian Journal of Hospital Pharmacy is copyrighted by the Canadian Society of Hospital Pharmacy. In submitting their manuscripts, the authors transfer, assign, and otherwise convey all copyright ownership to CSHP.
Entities:
Keywords:
artificial intelligence; literature review; pharmacy
Authors: Allan Fong; Nicole Harriott; Donna M Walters; Hanan Foley; Richard Morrissey; Raj R Ratwani Journal: Int J Med Inform Date: 2017-05-11 Impact factor: 4.046
Authors: Gabriel Chartrand; Phillip M Cheng; Eugene Vorontsov; Michal Drozdzal; Simon Turcotte; Christopher J Pal; Samuel Kadoury; An Tang Journal: Radiographics Date: 2017 Nov-Dec Impact factor: 5.333
Authors: Jonathan H Chen; Mary K Goldstein; Steven M Asch; Lester Mackey; Russ B Altman Journal: J Am Med Inform Assoc Date: 2017-05-01 Impact factor: 4.497
Authors: Ben Van Calster; Laure Wynants; Dirk Timmerman; Ewout W Steyerberg; Gary S Collins Journal: J Am Med Inform Assoc Date: 2019-12-01 Impact factor: 4.497